about
APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrateCocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trialIncreasing long-chain n-3PUFA consumption improves small peripheral artery function in patients at intermediate-high cardiovascular risk.FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway.Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases.Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.New insights into circulating FABP4: Interaction with cytokeratin 1 on endothelial cell membranes.Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa).Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease.Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk.HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages.FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants.Correction: FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway.Effect of the long-term regular intake of virgin olive oil on the phenolic metabolites in human fasting plasma.The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.Negative effect of a low-carbohydrate, high-protein, high-fat diet on small peripheral artery reactivity in patients with increased cardiovascular risk.2,4-Decadienal downregulates TNF-alpha gene expression in THP-1 human macrophages.Impaired vitamin E status in patients with parenchymal liver cirrhosis: relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma.Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers.Heterozygous familial hypercholesterolaemic patients have increased arterial stiffness, as determined using the augmentation index.Cytotoxic effects of the lipid peroxidation product 2,4-decadienal in vascular smooth muscle cells.Even low physical activity levels improve vascular function in overweight and obese postmenopausal women.Aldehydes mediate tissue factor induction: a possible mechanism linking lipid peroxidation to thrombotic events.Low-carbohydrate, high-protein, high-fat diet alters small peripheral artery reactivity in metabolic syndrome patients.Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis.Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.[Long-term effects of continuous positive airway pressure treatment on subclinical atherosclerosis in obstructive sleep apnoea syndrome].Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients.Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients.Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease.Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.Physical activity below the minimum international recommendations improves oxidative stress, ADMA levels, resting heart rate and small artery endothelial function.Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patientsHepatic production of apolar aldehydes in rats with carbon tetrachloride-induced cirrhosis
P50
Q28235497-46A19AC1-35EC-4B89-A114-2C7F0FDF9975Q28731712-35DAD2ED-2392-4266-801A-0F25CC83F0D6Q34415967-8EA28979-5F89-45DE-BF75-4AF73667B9FDQ35060802-451B6DC9-1040-456C-BF07-81899F47D315Q37150845-F61B044E-2E55-484B-8431-4A51DCD36C66Q38682013-9840C54E-3FDE-41AB-9D42-6966E7B4D231Q38837524-372714FA-A7B2-4283-8B8F-4CD42F14CA92Q38978160-B40CBAB7-DF27-4CBB-A5BF-A0BACEC81C53Q39249394-AE4811DD-A629-418B-A5D7-815F3AC04B19Q40052884-2BBCAE02-7946-4365-ADBF-3CF02D358149Q40633439-9847EC48-AD7F-459C-8D44-58824DAD5646Q40769629-D2C881B7-D605-47D5-BA7C-5EB6BBF49853Q43105252-6E11AF55-84C0-4967-B9F0-EE1D16D9D7CBQ43111854-6A72F57E-D3DA-43F2-BC2C-4FC5B6E70B2DQ43274356-B026FA5C-B7EA-4DBC-B73C-4C88F72C7C96Q43601442-026571BB-38B6-4EB9-A642-CC35732E89C0Q43704014-42837499-F541-4C8D-8A5B-4C291A845491Q43973178-689E4EF7-16A8-4D97-86CC-6D6F0638987FQ44204452-149E2815-618B-4E04-B2BA-6BD96EF83E11Q44510843-C46338F3-A71B-4B37-9F3A-4651A9334B02Q44551839-C42ABD16-94CE-498C-A481-AA9C10D3534CQ44553748-7D6ED31F-B9AC-4CB5-A16D-81B12B8FFAF5Q44645997-B4C1705E-48EA-43DB-A838-357E645A8725Q44864546-84FC4AF8-9C16-4515-BBB3-3DCED529569BQ47739407-0147C3AC-1DD7-4E65-B4C2-67B36C017D24Q49341653-8966BE86-98DB-4940-B06E-B229223C12F9Q50172167-DA5EB671-33C7-4DEC-8DCD-AA246AFD23CBQ50239479-EC39382B-8AC4-4227-AAC7-C1061383F2EBQ50775960-388767C9-07E7-47CA-82CA-766C04233908Q51385354-97CCF41E-2620-48BF-BE5E-AEE0A6E2A4EDQ51453108-2F806070-A47E-45B4-9E80-0754E302E68BQ51473734-5F7402AE-73F8-4B2F-A491-448BEA262CECQ51571152-D83D686E-03ED-478F-ACBF-BD7612CA1F8FQ51738923-CB2E8174-61D8-4E9E-9C2F-56C883AAF7E8Q53085754-B07688B4-28B8-42B5-AF21-21E946CAF64EQ53787101-45333C2F-D246-4336-BC2E-AB15BBEFD2B9Q54524130-218E7E85-3E03-4E8B-8A88-7626969A2192Q55025650-989B2041-957F-4233-9697-686033023D81Q59540609-81F26411-D3CA-4A46-A115-34C037D21C6CQ60664721-F1F1F51B-5F6B-471F-B7CE-B0335D9D95CD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Josefa Girona
@ast
Josefa Girona
@en
Josefa Girona
@es
Josefa Girona
@nl
Josefa Girona
@sl
type
label
Josefa Girona
@ast
Josefa Girona
@en
Josefa Girona
@es
Josefa Girona
@nl
Josefa Girona
@sl
prefLabel
Josefa Girona
@ast
Josefa Girona
@en
Josefa Girona
@es
Josefa Girona
@nl
Josefa Girona
@sl
P106
P21
P31
P496
0000-0002-6267-8779